Categories AlphaGraphs, Earnings, Technology

QCOM Earnings: Qualcomm Q4 revenues grow 12%; earnings top expectations

Chipmaker Qualcomm, Inc. (NASDAQ: QCOM) on Wednesday reported stronger-than-expected earnings and revenues for the fourth quarter of 2021 amid continued uptick in microprocessor demand across industries. The company also provided guidance for the first quarter.

Qualcomm Q4 2021 earnings infographic

At $9.34 billion, fourth-quarter revenues were up 12% from the prior-year quarter and well above the consensus forecast. The top-line benefited from the elevated chip demand and the company’s investments in 5G.

Net income was $2.79 billion or $2.45 per share, compared to $2.96 billion or $2.58 per share in the fourth quarter of 2020. Adjusted profit moved up to $2.55 per share from $1.45 per share last year and topped the Street view.


Read management/analysts’ comments on Qualcomm’s Q4 results


In the past twelve months, Qualcomm’s shares dropped around 6%. Following Wednesday’s earnings announcement, the stock made strong gains in the evening, after closing the regular session higher.

Prior Performance

  • Qualcomm Q1 2021 earnings

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

HP Inc. (HPQ) stock research summary | Q3 2021

HP Inc has shown a strong performance in Q4 2021. In spite of remote working, HP has shown a strong demand for PC and printer. The company has beat Zacks

VMware Inc. (VMW) stock research summary | Q3 2021

In this era of digital transformation, the technology industry is seeing a rapid influx of innovative products and solutions that help businesses adapt to the fast-changing and complex environment. VMware

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a record year though the rush led by the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top